Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic responseCentral MessagePerspective

Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic responseCentral MessagePerspective

Objective: The study objective was to assess the safety and efficacy of a preemptive direct-acting antiviral therapy in lung transplants from hepatitis C virus donors to uninfected recipients. Methods: This study is a prospective, open-label, nonrandomized, pilot trial. Recipients of hepatitis C vir...

Full description

Bibliographic Details
Main Authors: Mauricio A. Villavicencio, MD, Selena S. Li, MD, Ann Marie Leifer, NP, Jenna L. Gustafson, RN, Asishana Osho, MD, Stanley Wolfe, MD, Yuval Raz, MD, Jason Griffith, MD, PhD, Isabel Neuringer, MD, Emily Bethea, MD, Thais Gift, RPh, Georgina Waldman, RPh, Todd Astor, MD, Nathaniel B. Langer, MD, Raymond T. Chung, MD
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:JTCVS Open
Subjects:
lung transplantation
hepatitis C
outcomes
antivirals
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273623000712

Internet

http://www.sciencedirect.com/science/article/pii/S2666273623000712

Similar Items